Content Hub

2020 Preclinical IO Insights

Insights from Eric Ibsen, President & CEO, Studylog

Ahead of the 5th PREDiCT: Tumor Models for Immuno-Oncology Virtual Summit, (formerly catered for San Francisco community), on Jan 26 – 28 2021, we are excited to have a fireside chat with Eric Ibsen, President & CEO at Studylog, to hear how 2020 has shed new lights on preclinical IO researchers, and why a powerful software is critical to future studies.

TMSF Content Thumbnail (1)